Banff, Alberta, Canada
August 9-14, 2009
Rimrock Resort Hotel
10th Banff Conference on Allograft Pathology

Home Welcome About Banff Contact Us Sponsors

 

The Conference

Updates:

  • PowerPoint presentations are now being added to the programme section of the website.
  • Click here to view a summary report of the heart sessions.
  • Click here view the draft proposal for quality assurance from Dr. Michael Mengel.
  • Click here to complete the 2009 Banff Virtual Slide Test.
  • Dr. Volker Nickeleit has a questionnaire on BK nephropathy, and a questionnaire regarding polyomavirus nephropathies and concurrent rejection.

From August 9-14, 2009, the Rimrock Resort Hotel will hold the 10th Banff Conference on Allograft Pathology.

This conference will focus on a range of solid organ allografts, with a special focus on alloantibody responses and related phenotypes, role(s) of endothelial cells in allograft rejection, phenotyping late kidney transplant deterioration, non-invasive surrogate markers of rejection in various organs, genomics/proteomics approaches, and updates on kidney, pancreas, heart, liver, lung, and composite tissue graft pathology.  There will also be sessions on quality improvement in biopsy reading and high tech options for maintaining competence in transplant biopsy interpretation.

As an option, there will be scenic private conference tours of Banff for delegates and their families. All attendees will have the opportunity to participate in poster sessions, case presentations, and many discussions related to plenary and organ-specific sessions.

The objectives of this conference are:
  • to review classifications for kidney, liver, heart, lung, pancreas and composite
    tissue graft allograft pathology.
  • to discuss and conceptualize alloantibody responses and related phenotypes.
  • to discuss genomics/proteomics approaches to rejection diagnosis.
  • to review and update information about non-invasive surrogate markers of rejection
    in various organs.
  • to present and discuss role(s) of endothelial cells in allograft rejection.
  • to discuss phenotyping of late kidney transplant deterioration.
  • to discuss quality improvement in biopsy reading and high tech options for
    maintaining competence in transplant biopsy interpretation.

Copyright 1997-2009 Banff Conferences on Allograft Pathology. All Rights Reserved.